Coherent Expression Chromosome Cluster Analysis Reveals Differential Regulatory Functions of Amino-Terminal and Distal Parathyroid Hormone-Related Protein Domains in Prostate Carcinoma
暂无分享,去创建一个
[1] Nicolas Stransky,et al. Visualizing chromosomes as transcriptome correlation maps: evidence of chromosomal domains containing co-expressed genes--a study of 130 invasive ductal breast carcinomas. , 2005, Cancer research.
[2] M. Honda,et al. Genome-wide transcriptome mapping analysis identifies organ-specific gene expression patterns along human chromosomes. , 2004, Genomics.
[3] G. Hannon,et al. miRNAs on the move: miRNA biogenesis and the RNAi machinery. , 2004, Current opinion in cell biology.
[4] P. Cresswell. Cutting and Pasting Antigenic Peptides , 2004, Science.
[5] P. Cresswell. Cell biology. Cutting and pasting antigenic peptides. , 2004, Science.
[6] D. Grignon,et al. Role of Eicosanoids in Prostate Cancer Progression , 2004, Cancer and Metastasis Reviews.
[7] L. Deftos,et al. Amino-terminal and midmolecule parathyroid hormone-related protein, phosphatidylcholine, and type II cell proliferation in silica-injured lung. , 2003, American journal of physiology. Lung cellular and molecular physiology.
[8] N. Pećina-Šlaus. Tumor suppressor gene E-cadherin and its role in normal and malignant cells , 2003, Cancer Cell International.
[9] Adrian V. Lee,et al. Estrogen-mediated down-regulation of E-cadherin in breast cancer cells. , 2003, Cancer research.
[10] Wen-Chang Chang,et al. Depletion of phospholipid hydroperoxide glutathione peroxidase up‐regulates arachidonate metabolism by 12(S)‐lipoxygenase and cyclooxygenase 1 in human epidermoid carcinoma A431 cells , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[11] L. Deftos,et al. Parathyroid hormone-related protein ameliorates death receptor-mediated apoptosis in lung cancer cells. , 2003, American journal of physiology. Cell physiology.
[12] L. Deftos,et al. Proapoptotic effects of parathyroid hormone-related protein in type II pneumocytes. , 2003, American journal of respiratory cell and molecular biology.
[13] Hsueh-Kung Lin,et al. Role of human type 3 3alpha-hydroxysteroid dehydrogenase (AKR1C2) in androgen metabolism of prostate cancer cells. , 2003, Chemico-biological interactions.
[14] Charles Boone,et al. A conserved RING finger protein required for histone H2B monoubiquitination and cell size control. , 2003, Molecular cell.
[15] R. Terkeltaub,et al. Parathyroid hormone–related peptide is a naturally occurring, protein kinase A–dependent angiogenesis inhibitor , 2002, Nature Medicine.
[16] P. Esbrit,et al. Both N- and C-terminal Domains of Parathyroid Hormone-related Protein Increase Interleukin-6 by Nuclear Factor-κB Activation in Osteoblastic Cells* , 2002, The Journal of Biological Chemistry.
[17] M. Falzon,et al. Parathyroid hormone-related protein enhances PC-3 prostate cancer cell growth via both autocrine/paracrine and intracrine pathways , 2002, Regulatory Peptides.
[18] Hen-Li Chen,et al. Parathyroid Hormone and Parathyroid Hormone-related Protein Exert Both Pro- and Anti-apoptotic Effects in Mesenchymal Cells* , 2002, The Journal of Biological Chemistry.
[19] Y. Kawahito,et al. Expression of peroxisome proliferator‐activated receptor (PPAR) in human prostate cancer , 2002, The Prostate.
[20] K. Honn,et al. Mechanisms controlling cell cycle arrest and induction of apoptosis after 12-lipoxygenase inhibition in prostate cancer cells. , 2002, Cancer research.
[21] Xiaoli Shen,et al. Intracrine PTHrP protects against serum starvation-induced apoptosis and regulates the cell cycle in MCF-7 breast cancer cells. , 2002, Endocrinology.
[22] N. Shastri,et al. Producing nature's gene-chips: the generation of peptides for display by MHC class I molecules. , 2002, Annual review of immunology.
[23] J. Turnay,et al. Midregion Parathyroid Hormone‐Related Protein Inhibits Growth and Invasion In Vitro and Tumorigenesis In Vivo of Human Breast Cancer Cells , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[24] A. F. Stewart,et al. Printed in U.S.A. Copyright © 2001 by The Endocrine Society The C-Terminal Region of PTHrP, in Addition to the Nuclear Localization Signal, Is Essential for the Intracrine Stimulation of Proliferation in Vascular Smooth Muscle Cells , 2022 .
[25] B. Bass,et al. A Role for the RNase III Enzyme DCR-1 in RNA Interference and Germ Line Development in Caenorhabditis elegans , 2001, Science.
[26] Y. Ye,et al. Overexpression of parathyroid hormone-related protein promotes cell growth in the rat intestinal cell line IEC-6 , 2001, Regulatory Peptides.
[27] A. Caudy,et al. Role for a bidentate ribonuclease in the initiation step of RNA interference , 2001 .
[28] T. Tomasi,et al. Activation of MHC Class I, II, and CD40 Gene Expression by Histone Deacetylase Inhibitors1 , 2000, The Journal of Immunology.
[29] Michael E. Burczynski,et al. Human 3α-hydroxysteroid dehydrogenase isoforms (AKR1C1–AKR1C4) of the aldo-keto reductase superfamily: functional plasticity and tissue distribution reveals roles in the inactivation and formation of male and female sex hormones , 2000 .
[30] G. Church,et al. A computational analysis of whole-genome expression data reveals chromosomal domains of gene expression , 2000, Nature Genetics.
[31] M. Ashburner,et al. Gene Ontology: tool for the unification of biology , 2000, Nature Genetics.
[32] R. Nissenson,et al. Apoptosis mediated by activation of the G protein-coupled receptor for parathyroid hormone (PTH)/PTH-related protein (PTHrP). , 2000, Molecular endocrinology.
[33] D. Tindall,et al. Nonapoptotic cell death associated with S-phase arrest of prostate cancer cells via the peroxisome proliferator-activated receptor γ ligand, 15-deoxy-Δ12,14-prostaglandin J2 , 2000 .
[34] D. Tindall,et al. Nonapoptotic cell death associated with S-phase arrest of prostate cancer cells via the peroxisome proliferator-activated receptor gamma ligand, 15-deoxy-delta12,14-prostaglandin J2. , 2000, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[35] N. Palackal,et al. Human 3alpha-hydroxysteroid dehydrogenase isoforms (AKR1C1-AKR1C4) of the aldo-keto reductase superfamily: functional plasticity and tissue distribution reveals roles in the inactivation and formation of male and female sex hormones. , 2000, The Biochemical journal.
[36] K. Pienta,et al. Parathyroid hormone-related protein as a growth regulator of prostate carcinoma. , 1999, Cancer research.
[37] P. J. van den Elsen,et al. The common regulatory pathway of MHC class I and class II transactivation. , 1999, Microbes and infection.
[38] S. Rabbani,et al. Over‐production of parathyroid hormone–related peptide results in increased osteolytic skeletal metastasis by prostate cancer cells In vivo , 1999, International journal of cancer.
[39] Akira,et al. Identification of a principal mRNA species for human 3alpha-hydroxysteroid dehydrogenase isoform (AKR1C3) that exhibits high prostaglandin D2 11-ketoreductase activity. , 1998, Journal of biochemistry.
[40] W. Birchmeier,et al. Analysis of the E‐cadherin and P‐cadherin promoters in murine keratinocyte cell lines from different stages of mouse skin carcinogenesis , 1997, Molecular carcinogenesis.
[41] Y. Ichinose,et al. Tumor‐induced hypercalcemia and parathyroid hormone‐related protein in lung carcinoma , 1996, Cancer.
[42] L. Deftos,et al. Elimination of the carboxy-terminal sequences of parathyroid hormone-related protein 1-173 increases production and secretion of the truncated forms. , 1996, Endocrinology.
[43] S. Rabbani,et al. Regulation in vivo of the growth of Leydig cell tumors by antisense ribonucleic acid for parathyroid hormone-related peptide. , 1995, Endocrinology.
[44] P. Stern,et al. Loss of HLA class I expression in prostate cancer: implications for immunotherapy. , 1995, Urology.
[45] D. Riethmacher,et al. A targeted mutation in the mouse E-cadherin gene results in defective preimplantation development. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[46] Y. Hannun,et al. 12(S)-HETE enhancement of prostate tumor cell invasion: selective role of PKC alpha. , 1994, Journal of the National Cancer Institute.
[47] J. Orloff,et al. Parathyroid hormone-related protein as a prohormone: posttranslational processing and receptor interactions. , 1994, Endocrine reviews.
[48] J. Papadimitriou,et al. Tartrate resistant acid phosphatase activity in rat cultured osteoclasts is inhibited by a carboxyl terminal peptide (osteostatin) from parathyroid hormone‐related protein , 1993, Journal of cellular biochemistry.
[49] S. Segal,et al. The expression of HLA class I antigen in prostate cancer in relation to tumor differentiation and patient survival. , 1994, Cancer detection and prevention.
[50] M. Freeman,et al. Expression cloning of a common receptor for parathyroid hormone and parathyroid hormone-related peptide from rat osteoblast-like cells: a single receptor stimulates intracellular accumulation of both cAMP and inositol trisphosphates and increases intracellular free calcium. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[51] M. Drinkhill,et al. Stimulation of ovine placental transport of calcium and magnesium by mid‐molecule fragments of human parathyroid hormone‐related protein , 1990, Experimental physiology.
[52] D. Paulson,et al. Isolation of a human prostate carcinoma cell line (DU 145) , 1978, International journal of cancer.